Pacific Biosciences Of California Gross Margin 2012-2026 | PACB
Current and historical gross margin for Pacific Biosciences Of California (PACB) over the last 10 years. The current gross profit margin for Pacific Biosciences Of California as of March 31, 2026 is %.
| Pacific Biosciences Of California Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.16B | $0.06B | 38.13% |
| 2025-12-31 | $0.16B | $0.05B | 29.38% |
| 2025-09-30 | $0.15B | $0.04B | 25.97% |
| 2025-06-30 | $0.16B | $0.03B | 21.79% |
| 2025-03-31 | $0.15B | $0.03B | 16.45% |
| 2024-12-31 | $0.15B | $0.04B | 24.03% |
| 2024-09-30 | $0.17B | $0.04B | 21.39% |
| 2024-06-30 | $0.19B | $0.05B | 23.81% |
| 2024-03-31 | $0.20B | $0.06B | 27.36% |
| 2023-12-31 | $0.20B | $0.05B | 26.87% |
| 2023-09-30 | $0.17B | $0.05B | 28.82% |
| 2023-06-30 | $0.15B | $0.05B | 30.82% |
| 2023-03-31 | $0.13B | $0.05B | 33.83% |
| 2022-12-31 | $0.13B | $0.05B | 38.58% |
| 2022-09-30 | $0.14B | $0.06B | 44.85% |
| 2022-06-30 | $0.14B | $0.06B | 44.60% |
| 2022-03-31 | $0.14B | $0.06B | 44.44% |
| 2021-12-31 | $0.13B | $0.06B | 45.04% |
| 2021-09-30 | $0.12B | $0.05B | 43.44% |
| 2021-06-30 | $0.11B | $0.05B | 42.45% |
| 2021-03-31 | $0.09B | $0.04B | 41.30% |
| 2020-12-31 | $0.08B | $0.03B | 40.51% |
| 2020-09-30 | $0.08B | $0.03B | 42.50% |
| 2020-06-30 | $0.08B | $0.03B | 40.96% |
| 2020-03-31 | $0.09B | $0.04B | 40.66% |
| 2019-12-31 | $0.09B | $0.04B | 38.46% |
| 2019-09-30 | $0.08B | $0.03B | 33.73% |
| 2019-06-30 | $0.08B | $0.02B | 30.38% |
| 2019-03-31 | $0.08B | $0.02B | 30.26% |
| 2018-12-31 | $0.08B | $0.03B | 31.65% |
| 2018-09-30 | $0.08B | $0.03B | 33.33% |
| 2018-06-30 | $0.09B | $0.03B | 36.67% |
| 2018-03-31 | $0.09B | $0.03B | 36.36% |
| 2017-12-31 | $0.09B | $0.03B | 36.17% |
| 2017-09-30 | $0.10B | $0.04B | 37.89% |
| 2017-06-30 | $0.10B | $0.04B | 42.71% |
| 2017-03-31 | $0.10B | $0.04B | 45.36% |
| 2016-12-31 | $0.09B | $0.05B | 49.45% |
| 2016-09-30 | $0.10B | $0.06B | 59.41% |
| 2016-06-30 | $0.09B | $0.05B | 60.00% |
| 2016-03-31 | $0.09B | $0.06B | 61.70% |
| 2015-12-31 | $0.09B | $0.05B | 58.06% |
| 2015-09-30 | $0.07B | $0.03B | 43.24% |
| 2015-06-30 | $0.08B | $0.04B | 46.91% |
| 2015-03-31 | $0.07B | $0.03B | 38.81% |
| 2014-12-31 | $0.06B | $0.02B | 37.70% |
| 2014-09-30 | $0.05B | $0.02B | 41.51% |
| 2014-06-30 | $0.04B | $0.01B | 25.64% |
| 2014-03-31 | $0.03B | $0.01B | 23.53% |
| 2013-12-31 | $0.03B | $0.01B | 21.43% |
| 2013-09-30 | $0.03B | $0.00B | 16.00% |
| 2013-06-30 | $0.02B | $0.00B | 14.29% |
| 2013-03-31 | $0.02B | $0.00B | 9.09% |
| 2012-12-31 | $0.03B | $0.00B | 3.85% |
| 2012-09-30 | $0.03B | $0.00B | 6.25% |
| 2012-06-30 | $0.04B | $0.01B | 12.50% |
| 2012-03-31 | $0.04B | $0.01B | 29.55% |
| 2011-12-31 | $0.03B | $0.01B | 38.24% |
| 2011-09-30 | $0.02B | $0.01B | 50.00% |
| 2011-06-30 | $0.01B | $0.01B | 72.73% |
| 2011-03-31 | $0.00B | $0.00B | 100.00% |
| 2010-12-31 | $0.00B | $0.00B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.405B | $0.160B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |